A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Jesus Garcia-Donas, Elizabeth M Swisher, Anne Floquet, Gottfried E Konecny, Iain A McNeish, Clare L Scott, Terri Cameron, Lara Maloney, Jeff Isaacson, Sandra Goble, Caroline Grace, Thomas C Harding, Mitch Raponi, James Sun, Kevin K Lin, Heidi Giordano, Jonathan A Ledermann. Lancet 2017
Times Cited: 561




List of shared articles



Times cited

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
Gonzalo Giornelli, Dolores Gallardo, Roberto Hegg, Gonzalo Gomez Abuin, Maximo De La Vega, Maria Lim-Law, Valeria Caceres, Lina Trujillo, Maria Del Pilar Estevez-Diz, Cristian Pacheco,[...]. Future Oncol 2021
0

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Jeffrey A How, Amir A Jazaeri, Bryan Fellman, Molly S Daniels, Suzanna Penn, Cara Solimeno, Ying Yuan, Kathleen Schmeler, Jerry S Lanchbury, Kirsten Timms,[...]. Cancers (Basel) 2021
2


Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Gang Ji, Qianlan Yao, Longlong Bao, Jing Zhang, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Rui Bi, Xiaoyan Zhou. Ann Transl Med 2021
0


Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
7

Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
Soledad Jorge, Andrew S McFaddin, Kemi M Doll, Kathryn P Pennington, Barbara M Norquist, Robin L Bennett, Colin C Pritchard, Elizabeth M Swisher. Gynecol Oncol 2020
6

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, Nicole N Boucicaut, Melissa Henson, Alexia Iasonos, Qin Zhou, Debra M Sarasohn, Jacqueline Gallagher, Sara Kravetz,[...]. Gynecol Oncol 2020
1

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1



Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1